ריזדרונט טבע ® 75 מ"ג
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
RISEDRONIC ACID SODIUM 75 MG
Disponibbli minn:
ABIC MARKETING LTD
Kodiċi ATC:
M05BA07
Għamla farmaċewtika:
TABLETS
Rotta amministrattiva:
PER OS
Manifatturat minn:
TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY
Grupp terapewtiku:
RISEDRONIC ACID
Indikazzjonijiet terapewtiċi:
Treatment of osteoporosis in postmenopausal women at increased risk of fractures.Prevention of osteoporosis in postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and to reduce the risk of fracture.
Data ta 'l-awtorizzazzjoni:
2012-07-01
